Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00489866
Status:
COMPLETED
Last Update Posted:
2015-03-31
First Post:
2007-06-20
Brief Title:
Aripiprazole Augmentation of Antidepressants in PTSD
Sponsor:
Durham VA Medical Center
Organization:
Durham VA Medical Center
Study Overview
Official Title:
Aripiprazole Augmentation of Antidepressants in PTSD
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder PTSD symptoms cognitive symptoms psychotic symptoms and depressive symptoms in veterans with PTSD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None